UPI Related Analyst Ratings
-
MLV & Co. Downgrades Uroplasty (UPI) to Hold
-
JMP Securities Downgrades Uroplasty (UPI) to Market Perform
-
Stephens Starts Uroplasty (UPI) at Overweight
-
JMP Securities Upgrades Uroplasty (UPI) to Market Outperform
-
Roth Capital Upgrades Uroplasty (UPI) to Buy
-
Dougherty & Co Affirms 'Buy' on Uroplasty (UPI); Allergan's (AGN) Entry Is Slight Positive...Near-Term
-
McNicoll Lewis & Vlak Starts Uroplasty (UPI) at Buy
-
JMP Securities Downgrades Uroplasty (UPI) to Market Perform
-
Roth Capital Downgrades Uroplasty (UPI) to Neutral
-
JMP Securities Initiates Coverage on Uroplasty (UPI) with a Market Outperform
-
Roth Capital Initiates Coverage on Uroplasty (UPI) with a 'Buy'
Back to UPI Stock Lookup
